Jun Justin Luo Sells 70,440 Shares of 111 (NASDAQ:YI) Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jun Justin Luo sold 70,440 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $0.25, for a total transaction of $17,610.00. Following the completion of the sale, the director owned 710,551 shares in the company, valued at $177,637.75. The trade was a 9.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jun Justin Luo also recently made the following trade(s):

• On Tuesday, May 26th, Jun Justin Luo sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Price Performance

NASDAQ YI opened at $5.47 on Friday. The company’s 50 day simple moving average is $6.29 and its 200 day simple moving average is $5.58. 111, Inc. Sponsored ADR has a 12 month low of $2.48 and a 12 month high of $11.17. The company has a market capitalization of $48.08 million, a P/E ratio of -5.47 and a beta of 0.66.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.